Daiichi Sankyo Company Limited
Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally. The company offers Enhertu to treat patients with HER2 positive and low breast cancer, HER2 positive gastric or gastroesophageal junction adenocarcinoma, and HER2 positive solid tumors; Turalio, an oral small molecule that targets colony stimulating factor 1 rec… Read more
Daiichi Sankyo Company Limited (DSKYF) - Total Liabilities
Latest total liabilities as of December 2025: $2.11 Trillion USD
Based on the latest financial reports, Daiichi Sankyo Company Limited (DSKYF) has total liabilities worth $2.11 Trillion USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Daiichi Sankyo Company Limited - Total Liabilities Trend (2003–2025)
This chart illustrates how Daiichi Sankyo Company Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Daiichi Sankyo Company Limited Competitors by Total Liabilities
The table below lists competitors of Daiichi Sankyo Company Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kinross Gold Corporation
NYSE:KGC
|
USA | $4.04 Billion |
|
The Kroger Co.
SA:K1RC34
|
Brazil | R$44.34 Billion |
|
PetroChina Company Limited
F:PC6
|
Germany | €1.10 Trillion |
|
Constellation Software Inc
PINK:CNSWF
|
USA | $11.21 Billion |
|
DNB Bank ASA
PINK:DNBBY
|
USA | $3.40 Trillion |
|
Cenovus Energy Inc
NYSE:CVE
|
USA | $31.76 Billion |
|
EQT Corporation
NYSE:EQT
|
USA | $14.40 Billion |
|
Dai-ichi Life Holdings Inc
PINK:DLICY
|
USA | $68.35 Trillion |
Liability Composition Analysis (2003–2025)
This chart breaks down Daiichi Sankyo Company Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Daiichi Sankyo Company Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Daiichi Sankyo Company Limited (2003–2025)
The table below shows the annual total liabilities of Daiichi Sankyo Company Limited from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $1.83 Trillion | +3.39% |
| 2024-03-31 | $1.77 Trillion | +67.69% |
| 2023-03-31 | $1.06 Trillion | +22.22% |
| 2022-03-31 | $864.87 Billion | +7.17% |
| 2021-03-31 | $807.03 Billion | +1.96% |
| 2020-03-31 | $791.55 Billion | -5.58% |
| 2019-03-31 | $838.34 Billion | +9.63% |
| 2018-03-31 | $764.71 Billion | +2.85% |
| 2017-03-31 | $743.54 Billion | +11.56% |
| 2016-03-31 | $666.51 Billion | -1.29% |
| 2015-03-31 | $675.25 Billion | -20.23% |
| 2014-03-31 | $846.51 Billion | +13.40% |
| 2013-03-31 | $746.47 Billion | +6.20% |
| 2012-03-31 | $702.89 Billion | +18.62% |
| 2011-03-31 | $592.54 Billion | -1.24% |
| 2010-03-31 | $600.00 Billion | -0.99% |
| 2009-03-31 | $605.98 Billion | +148.99% |
| 2008-03-31 | $243.38 Billion | -33.26% |
| 2007-03-31 | $364.69 Billion | +5.10% |
| 2006-03-31 | $346.99 Billion | +38.68% |
| 2005-03-31 | $250.21 Billion | +6.11% |
| 2004-03-31 | $235.81 Billion | -5.19% |
| 2003-03-31 | $248.70 Billion | -- |